Referred to the House Committee on Energy and Commerce.
Email me when HR 10197 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 10197. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The Biosecurity Modernization and Innovation Act obligates any business that sells nucleic acids or DNA‑synthesis equipment to check who is buying, why they need the material, and whether the sequence is on a government‑maintained “covered” list. Companies must refuse risky sales, keep records for at least five years, and notify the Secretary of Commerce of any suspected national‑security threat. The law adds civil penalties, reporting requirements and preempts conflicting state rules while preserving consumer‑protection and public‑health laws.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 10197
3 free questions a day, no accountSponsors
- Rep. Pfluger, August [R-TX-11] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 10197 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10197 freeOr ask your AI assistant about HR 10197 directly:
Add to Claude, ChatGPT or Cursor